Please Wait

Applying Filters...

Top first-in-class drug candidates of 2025: Ionis’ donidalorsen, Sanofi’s fitusiran, Cytokinetics’ aficamten await FDA approval

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

Dexmedetomidine

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

48 API Suppliers, 19 USDMF, 5 JDMF, 5 EU WC, 13 KDMF, 16 NDC API, 8 VMF, 32 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

42 Drugs in Development

42 Drugs in Development

FINISHED DOSAGE FORMULATIONS

97 FDF Dossiers, 60 FDA Orange Book, 6 Europe, 17 Canada, 3 South Africa, 11 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAVENOUS - EQ 1MG BASE/10ML (EQ 100MCG BASE/ML), SOLUTION;INTRAVENOUS - EQ 200MCG BASE/50ML (EQ 4MCG BASE/ML), SOLUTION;INTRAVENOUS - EQ 400MCG BASE/4ML (EQ 100MCG BASE/ML), SOLUTION;INTRAVENOUS - EQ 400MCG BASE/100ML (EQ 4MCG BASE/ML), INJECTABLE;INJECTION - EQ 1MG BASE/250ML (EQ 4MCG BASE/ML), INJECTABLE;INJECTION - EQ 200MCG BASE/2ML (EQ 100MCG BASE/ML), INJECTABLE;INJECTION - EQ 200MCG BASE/50ML (EQ 4MCG BASE/ML), INJECTABLE;INJECTION - EQ 400MCG BASE/100ML (EQ 4MCG BASE/ML), INJECTABLE;INJECTION - EQ 80MCG BASE/20ML (EQ 4MCG BASE/ML)

RELATED EXCIPIENT COMPANIES

2 Actylis

2 Actylis

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 54 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

4 Regulatory FDF Prices, 4 Annual Reports

MARKET PLACE

21 APIs, 8 FDF Dossiers

PATENTS & EXCLUSIVITIES

70 US Patents, 9 US Exclusivities, 3 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 USP, 1 Others

$ Xls download

Filters

Log in to access your PharmaMiles and download the data

Last Updated on PharmaCompass	Virtual Booth	Country	Name of the Firm	Written Confirmation No.	Product Name	Issue Date	Valid Till	Address of the Firm
13/08/2021	Emcure Pharmaceuticals	India	M/s Emcure Pharmaceuticals Ltd	WC-0226	Dexmedetomidine Hydrochloride USP	2019-10-07	2022-07-02	D-24 and D24/1 MIDC Kurkumbh Tal. Daund, Dist Pune 413 802, Maharashtra State
18/04/2020	GLAND PHARMA LIMITED	India	Gland Pharma Limited	WC-0427A3-4	Dexmedetomidine HCL USP	2022-08-04	2025-03-04	Plot No.49 & 50, J.N. Pharma City, Parawada (M), Visakhapatnam - 531019, Andhra Pradesh, India\r\n

Contact us
to update this info

Dexmedetomidine

Dexmedetomidine

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

48 API Suppliers

19 USDMF

5 JDMF

5 EU WC

13 KDMF

16 NDC API

8 VMF

32 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

42 Drugs in Development

FINISHED DOSAGE FORMULATIONS

97 FDF Dossiers

60 FDA Orange Book

6 Europe

17 Canada

3 South Africa

11 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAVENOUS - EQ 1MG BASE/10ML (EQ 100MCG BASE/ML)

SOLUTION;INTRAVENOUS - EQ 200MCG BASE/50ML (EQ 4MCG BASE/ML)

SOLUTION;INTRAVENOUS - EQ 400MCG BASE/4ML (EQ 100MCG BASE/ML)

SOLUTION;INTRAVENOUS - EQ 400MCG BASE/100ML (EQ 4MCG BASE/ML)

INJECTABLE;INJECTION - EQ 1MG BASE/250ML (EQ 4MCG BASE/ML)

INJECTABLE;INJECTION - EQ 200MCG BASE/2ML (EQ 100MCG BASE/ML)

INJECTABLE;INJECTION - EQ 200MCG BASE/50ML (EQ 4MCG BASE/ML)

INJECTABLE;INJECTION - EQ 400MCG BASE/100ML (EQ 4MCG BASE/ML)

INJECTABLE;INJECTION - EQ 80MCG BASE/20ML (EQ 4MCG BASE/ML)

RELATED EXCIPIENT COMPANIES

2 Actylis

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow

54 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

4 Regulatory FDF Prices

4 Annual Reports

MARKET PLACE

21 APIs

8 FDF Dossiers

PATENTS & EXCLUSIVITIES

70 US Patents

9 US Exclusivities

3 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 USP

1 Others

Filters